Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study of Safety and Feasibility of Bilateral Middle Meningeal Artery Embolization (bMMAE) in Patients With Refractory Chronic Migraine Headache: The MMAE-MIGRAINE Trial

NCT07223008 is registered in ClinicalTrials.gov with Johns Hopkins University as lead sponsor.

NCT NCT07223008
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07223008 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study of Safety and Feasibility of Bilateral Middle Meningeal Artery Embolization (bMMAE) in Patients With Refractory Chronic Migraine Headache: The MMAE-MIGRAINE Trial
Lead sponsor
Johns Hopkins University
Phase
Not applicable
Overall status
Recruiting
Start date
April 24, 2026
Completion date
April 30, 2028
Enrollment
13 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic migraine headache, migraine, refractory migraine